The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?
- 1 December 1996
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 86 (12) , 1709-1712
- https://doi.org/10.2105/ajph.86.12.1709
Abstract
BACKGROUND: Although the targeting of human immunodeficiency virus (HIV) prevention to high-risk populations has been widely discussed, its benefits have not been quantified. METHODS: This analysis of cost-effectiveness combines an HIV epidemic model, target population scenarios, and data on the cost and impact of prevention. RESULTS: The number of HIV infections averted in 5 years with $1 million in annual prevention spending ranges from 164 in high-risk populations to 0.4 in very-low-risk populations. Fortyfold to two-hundredfold differences in prevention costs could equalize HIV infections averted. CONCLUSIONS: Targeting appears to provide substantial benefit and should be considered in allocation decisions about prevention.Keywords
This publication has 19 references indexed in Scilit:
- Maintaining low HIV seroprevalence in populations of injecting drug usersPublished by American Medical Association (AMA) ,1995
- How effective are risk-reduction interventions targeting injecting drug users?AIDS, 1994
- Prevention of HIV infectionAIDS, 1994
- HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative samplePublished by American Medical Association (AMA) ,1994
- Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men. The San Francisco/Berkeley Young Men's SurveyPublished by American Medical Association (AMA) ,1994
- HIV seroconversion in intravenous drug users in San Francisco, 1985–1990AIDS, 1994
- Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992Published by American Medical Association (AMA) ,1994
- AIDS policy: two divisive issuesPublished by American Medical Association (AMA) ,1993
- AIDS policy. Two divisive issuesJAMA, 1993
- HIV among drug injectors: The epidemic and the responseAIDS Care, 1991